Replies to post #95139 on Derf's Grotto

[earlylight]

.BRIEF-U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's humira
March 30, 2017 07:28 AM ET
Reuters
.
BRIEF- U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's humira. *U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's Humira prescribing information. *U.S. FDA approves addition of moderate to severe fingernail psoriasis data to Abbvie's Humira prescribing information.
Read more

[**D*A**]

I like GLW for the same reason. They also have a buyback in place and just increased the divy.